SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-054183
Filing Date
2020-11-16
Accepted
2020-11-16 16:15:49
Documents
67
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pand-10q_20200930.htm 10-Q 3426746
2 EX-31.1 pand-ex311_8.htm EX-31.1 19111
3 EX-31.2 pand-ex312_9.htm EX-31.2 19113
4 EX-32.1 pand-ex321_7.htm EX-32.1 9063
5 EX-32.2 pand-ex322_6.htm EX-32.2 9064
  Complete submission text file 0001564590-20-054183.txt   9251622

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pand-20200930.xml EX-101.INS 1730255
7 XBRL TAXONOMY EXTENSION SCHEMA pand-20200930.xsd EX-101.SCH 56025
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pand-20200930_cal.xml EX-101.CAL 34412
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pand-20200930_def.xml EX-101.DEF 249525
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pand-20200930_lab.xml EX-101.LAB 409213
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pand-20200930_pre.xml EX-101.PRE 351799
Mailing Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472 617-393-5925
Pandion Therapeutics, Inc. (Filer) CIK: 0001807901 (see all company filings)

IRS No.: 833015614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39381 | Film No.: 201317106
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences